Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

Cited by (262)

Items 101–200 of 262

1. Emergence of multiple SARS-CoV-2 mutations in an immunocompromised host
   Elham Khatamzas, Alexandra Rehn, Maximilian Muenchhoff, Johannes C. Hellmuth, Erik Gaitzsch, Tobias Weiglein, Enrico Georgi, Clemens Scherer, Stephanie Susanne Stecher, Oliver Weigert et al. · 2021 · medRxiv
2. Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2
   Laura Pérez‐Lago, Teresa Aldámiz‐Echevarría, Rita García‐Martínez, Leire Perez Latorre, Marta Herránz, Pedro J. Sola‐Campoy, Julia Suárez‐González, Carolina Martínez‐Laperche, Iñaki Comas, Fernando Gónzález‐Candelas et al. · 2021 · Biomedicines
3. Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance
   Nathan J. Zelyas, Kanti Pabbaraju, Matthew A. Croxen, Tarah Lynch, Emily Buss, Stephanie A. Murphy, Sandy Shokoples, Anita A. Wong, Jamil N. Kanji, Graham A. Tipples · 2021 · Microbiology Spectrum
4. Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative
   Sameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S Rajmani, Randhir Singh, Suman Pandey, Sahil Kumar, Sara Khaleeq, Petrus Jansen van Vuren, Shane Riddell, Sarah Goldie et al. · 2021 · ACS Infectious Diseases
5. A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020
   Broňa Brejová, Kristína Boršová, Viktória Hodorová, Viktória Čabanová, Lenka Reizigová, Evan David Paul, Pavol Čekan, Boris Klempa, Jozef Nosek, Tomáš Vinař · 2021 · Virus Genes
6. Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
   Halie M. Rando, Adam L. MacLean, Alexandra J. Lee, Ronan Lordan, Sandipan Ray, Vikas Bansal, Ashwin N. Skelly, Elizabeth Sell, John J. Dziak, Lamonica Shinholster et al. · 2021 · mSystems
7. Rapid inactivation of SARS-CoV-2 by titanium dioxide surface coating
   Petra Micochova, Ambika Chadha, Timi Hesseloj, Franca Fraternali, Jeremy J. Ramsden, Ravindra K. Gupta · 2021 · Wellcome Open Research
8. The variants of SARS‐CoV‐2 and the challenges of vaccines
   Xiucui Han, Qing Ye · 2021 · Journal of Medical Virology
9. Glycan-Based Flow-Through Device for the Detection of SARS-COV-2
   Alexander N. Baker, Sarah‐Jane Richards, Sarojini Pandey, Collette S. Guy, Ashfaq Ahmad, Muhammad Hasan, Caroline I. Biggs, Panagiotis G. Georgiou, Alexander J. Zwetsloot, Anne Straube et al. · 2021 · ACS Sensors
10. S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the US
    Nicole L. Washington, Simon J. White, Kelly M. Schiabor Barrett, Elizabeth T. Cirulli, Alexandre Bolze, James T. Lu · 2020 · medRxiv
11. Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2
    Samuel J. Dicken, Matthew J Murray, Lucy Thorne, Ann‐Kathrin Reuschl, Calum Forrest, Maaroothen Ganeshalingham, Luke Muir, Mphatso D. Kalemera, Machaela Palor, Laura E. McCoy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
12. Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model
    Denicar Lina Nascimento Fabris Maeda, Debin Tian, Hanna Yu, Nakul Dar, Vignesh Rajasekaran, Sarah Meng, Hassan M. Mahsoub, Harini Sooryanarain, Bo Wang, Connie Lynn Heffron et al. · 2021 · Proceedings of the National Academy of Sciences
13. Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351
    Nisha Bhattarai, Prabin Baral, Bernard S. Gerstman, Prem P. Chapagain · 2021 · The Journal of Physical Chemistry B
14. Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
    Ricardo Ariel Zimerman, Patrícia Aline Gröhs Ferrareze, Flavio Cadegiani, Carlos Gustavo Wambier, Daniel do Nascimento Fonseca, Andrea Roberto de Souza, Andy Goren, Liane Nanci Rotta, Zhihua Ren, Claudia Elizabeth Thompson · 2022 · Frontiers in Medicine
15. Genomic characterization of SARS‐CoV‐2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins
    Erdem Şahin, Gülendam Bozdayı, Selin Yiğit, Hager Muftah, Murat Dizbay, Özlem Güzel Tunçcan, Işıl Fidan, Kayhan Çağlar · 2021 · Journal of Medical Virology
16. The Emergence and Spread of Novel SARS-CoV-2 Variants
    Huaimin Yi, Jin Wang, Jiong Wang, Yuying Lu, Yali Zhang, Ruihao Peng, Jiahai Lu, Zeliang Chen · 2021 · Frontiers in Public Health
17. Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7
    Dominik Sebastian Nörz, Moritz Grunwald, Flaminia Olearo, Nicole Fischer, Martin Aepfelbacher, Susanne Pfefferle, Marc Lütgehetmann · 2021 · Journal of Clinical Virology
18. Nanopore sequencing of SARS-CoV-2: Comparison of short and long PCR-tiling amplicon protocols
    Broňa Brejová, Kristína Boršová, Viktória Hodorová, Viktória Čabanová, Askar Gafurov, Dominika Fričová, Martina Neboháčová, Tomáš Vinař, Boris Klempa, Jozef Nosek · 2021 · PLoS ONE
19. Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
    Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, Yidan Qiao, Yingtong Lin, Xin He, Hui Zhang · 2021 · Cellular and Molecular Immunology
20. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation
    José Arturo Molina-Mora, Estela Cordero-Laurent, Adriana Godínez, Melany Calderón-Osorno, Hebleen Brenes, Claudio Soto-Garita, Cristian Pérez-Corrales, COINGESA-CR Consorcio Interinstitucional de Estudios Genómicos del SARS-CoV-2 Costa Rica, Jan Felix Drexler, Andrés Moreira‐Soto et al. · 2021 · Infection Genetics and Evolution
21. Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta
    Janina Auth, Maria Fröba, Maximilian Große, Pia Rauch, Natalia Ruétalo, Michael Schindler, Martina Morokutti-Kurz, Philipp Graf, Andrea Dolischka, Eva Prieschl‐Grassauer et al. · 2021 · International Journal of Molecular Sciences
22. A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)
    Kristin Widyasari, Jin Nam Kim · 2023 · Antibodies
23. SARS‐CoV‐2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time‐course study – potential challenge for vaccines and therapies
    Stefanie Weber, Christina M. Ramirez, Barbara Weiser, Harold Burger, Walter Doerfler · 2021 · EMBO Molecular Medicine
24. Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
    Kim Tien Ng, Nur Khairiah Mohd-Ismail, Yee‐Joo Tan · 2021 · Vaccines
25. SARS-CoV-2 cell entry and targeted antiviral development
    Zinuo Chen, Ruikun Du, Jazmin Galván Achi, Lijun Rong, Qinghua Cui · 2021 · Acta Pharmaceutica Sinica B
26. Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants
    Elizabeth A. Jaworski, Rose M. Langsjoen, Brooke M. Mitchell, Barbara M. Judy, Patrick C. Newman, Jessica A. Plante, Kenneth S. Plante, Aaron L. Miller, Yiyang Zhou, Daniele M. Swetnam et al. · 2021 · eLife
27. Inferring transmission fitness advantage of SARS-CoV-2 variants of concern from wastewater samples using digital PCR, Switzerland, December 2020 through March 2021
    Lea Caduff, David Dreifuss, Tobias Schindler, Alexander J. Devaux, Pravin Ganesanandamoorthy, Anina Kull, Elyse Stachler, Xavier Fernandez-Cassi, Niko Beerenwinkel, Tamar Kohn et al. · 2022 · Eurosurveillance
28. First detection of an Italian human-to-cat outbreak of SARS-CoV-2 Alpha variant – lineage B.1.1.7
    Roberto Zoccola, Chiara Beltramo, Gabriele Magris, Simone Peletto, Pier Luigi Acutis, Elena Maria Bozzetta, Slobodanka Radović, Francesco Zappulla, Anna Maria Porzio, Maria Silvia Gennero et al. · 2021 · One Health
29. Catching SARS-CoV-2 by Sequence Hybridization: a Comparative Analysis
    Alexandra Rehn, Peter R. Braun, Mandy Knüpfer, Roman Wölfel, Markus H. Antwerpen, Mathias C. Walter · 2021 · mSystems
30. Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2)
    Erman Salih Istıflı, Paulo A. Netz, Arzuhan Sihoglu Tepe, Cengiz Sarıkürkçü, Bektaş Tepe · 2021 · Journal of Biomolecular Structure and Dynamics
31. Molecular Beacons Allow Specific RT-LAMP Detection of B.1.1.7 Variant SARS-CoV-2
    Scott A. Sherrill-Mix, Gregory D. Van Duyne, Frederic D. Bushman · 2021 · Journal of Biomolecular Techniques JBT
32. COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks
    Chandran Murugan, Sharmiladevi Ramamoorthy, Guru Prasad Kuppuswamy, Rajesh Kumar Murugan, Yuvaraj Sivalingam, Anandhakumar Sundaramurthy · 2021 · International Journal of Biological Macromolecules
33. COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study
    Trung Nguyen, Mehnaz Adnan, Binh Phu Nguyen, Joep de Ligt, Jemma L. Geoghegan, Richard A. Dean, Sarah Jefferies, Michael George Baker, Winston K.G. Seah, Andrew A. Sporle et al. · 2021 · The Lancet Regional Health - Western Pacific
34. Wastewater surveillance for SARS-CoV-2 in a small coastal community: Effects of tourism on viral presence and variant identification among low prevalence populations
    Andrew L. Rainey, Julia C. Loeb, Sarah E. Robinson, John A. Lednicky, John McPherson, Sue Colson, Michael J. Allen, Eric Stephen Coker, Tara Sabo‐Attwood, Anthony T. Maurelli et al. · 2021 · Environmental Research
35. Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2
    Qiaoli Peng, Runhong Zhou, Na Liu, Hui Wang, Haoran Xu, Meiqing Zhao, Dawei Yang, Ka‐Kit Au, Haode Huang, Li Liu et al. · 2022 · Cellular and Molecular Immunology
36. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
    Martin Sebastian Winkler, Tomasz Skirecki, Frank Martin Brunkhorst, Sara Cajander, Jean‐Marc Cavaillon, Ricard Ferrer, Stefanie B. Flohé, Alberto García‐Salido, Evangelos J. Giamarellos‐Bourboulis, Massimo Girardis et al. · 2021 · EBioMedicine
37. All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes
    Saheb Dutta, Bhavana Panthi, Amalendu Chandra · 2022 · The Journal of Physical Chemistry B
38. More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation
    Kamilla Toon, Emma M. Bentley, Giada Mattiuzzo · 2021 · Viruses
39. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
    Benjamin Trinité, Edwards Pradenas, Sílvia Marfil, Carla Rovirosa, Víctor Urrea, Ferran Tarrés-Freixas, Raquel Ortiz, Jordi Rodon, Júlia Vergara‐Alert, Joaquím Segalés et al. · 2021 · Viruses
40. Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection
    Congshan Jiang, Xiaowei Li, Changrong Ge, Yuanyuan Ding, Tao Zhang, Shuai Cao, Liesu Meng, Shemin Lu · 2021 · Journal of Pharmaceutical Analysis
41. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India
    Pushpendra Singh, Kuldeep Kumar Sharma, Priyanka Singh, Anudita Bhargava, Sanjay Singh Negi, Pratibha Sharma, Mayuri Pramod Bhise, Manish Kumar Tripathi, Atul Jindal, Nitin Madhusudan Nagarkar · 2022 · Microbial Pathogenesis
42. Impact of essential workers in the context of social distancing for epidemic control
    William R. Milligan, Zachary L. Fuller, Ipsita Agarwal, Michael B. Eisen, Molly Przeworski, Guy Sella · 2021 · PLoS ONE
43. Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures
    Santiago Justo Arévalo, Daniela Zapata Sifuentes, César J. Huallpa, Gianfranco Landa Bianchi, Adriana Castillo Chávez, Romina Garavito-Salini Casas, Carmen Sofia Uribe Calampa, Guillermo Uceda-Campos, Roberto Pineda · 2021 · Scientific Reports
44. SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response
    Chanchan Xiao, Lipeng Mao, Zhigang Wang, Lijuan Gao, Guodong Zhu, Jun Su, Xiongfei Chen, Jun Yuan, Yutian Hu, Zhinan Yin et al. · 2022 · iScience
45. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic
    Muhammad Zeeshan Anwar, Madeeha Shahzad Lodhi, Muhammad Tahir Khan, Malik Ihsanullah Khan, Sumaira Sharif · 2022 · Genes
46. The Comparison of Mutational Progression in SARS-CoV-2: A Short Updated Overview
    Abeer Asif, Iqra Ilyas, Mohammad Abdullah, Sadaf Sarfraz, Muhammad Mustafa, Arif Mahmood · 2022 · Journal of Molecular Pathology
47. A phylogeny-based metric for estimating changes in transmissibility from recurrent mutations in SARS-CoV-2
    Damien Richard, Liam P. Shaw, Robert Lanfear, Russell B Corbett-Detig, Angie S. Hinrichs, Jakob McBroome, Yatish Turakhia, Mislav Acman, Christopher J. Owen, Cedric C.S. Tan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
48. SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
    Daniel Martin Altmann, Catherine J. Reynolds, Rosemary Jane Boyton · 2021 · Cell Reports Medicine
49. Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19
    Fatah Chérifi, Fatima Laraba‐Djebari · 2021 · The Protein Journal
50. Highly Sensitive Detection Method for HV69-70del in SARS-CoV-2 Alpha and Omicron Variants Based on CRISPR/Cas13a
    Mengwei Niu, Yao Han, Xue Dong, Lan Yang, Fan Li, Youcui Zhang, Qiang Hu, Xueshan Xia, Hao Li, Yansong Sun · 2022 · Frontiers in Bioengineering and Biotechnology
51. Chronic SARS-CoV-2 infection and viral evolution in a hypogammaglobulinaemic individual
    Maia Kavanagh Williamson, Fergus Hamilton, Stephanie Hutchings, Hannah M. Pymont, Mark Hackett, David Arnold, Nick A. Maskell, Alasdair P. MacGowan, Mahableshwar Albur, Megan H. Jenkins et al. · 2021 · medRxiv
52. Evolutionary Dynamics of Indels in SARS-CoV-2 Spike Glycoprotein
    R. Shyama Prasad Rao, Nagib Ahsan, Chunhui Xu, Lingtao Su, Jacob C. Verburgt, Luca Fornelli, Daisuke Kihara, Dong He Xu · 2021 · Evolutionary Bioinformatics
53. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
    Mahda Delshad, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Davood Bashash · 2022 · International Immunopharmacology
54. Comparative phylogenetic analysis of SARS-CoV-2 spike protein—possibility effect on virus spillover
    Abozar Ghorbani, Samira Samarfard, Neda Eskandarzade, Alireza Afsharifar, Mohammad Hadi Eskandari, Ali Niazi‎, K. Izadpanah, Thomas P. Karbanowicz · 2021 · Briefings in Bioinformatics
55. Rapid Automated Screening for SARS-CoV-2 B.1.617 Lineage Variants (Delta/Kappa) through a Versatile Toolset of qPCR-Based SNP Detection
    Dominik Sebastian Nörz, Moritz Grunwald, Hui Ting Tang, Flaminia Olearo, Thomas Günther, Alexis Robitaille, Nicole Fischer, Adam T. Grundhoff, Martin Aepfelbacher, Susanne Pfefferle et al. · 2021 · Diagnostics
56. Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations
    Mohamed A Hendy, Samuel Kaufman, Mauricio Rene Ponga · 2021 · Scientific Reports
57. Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
    Jozef Dingemans, Brian M. J. W. van der Veer, Koen M. F. Gorgels, Volker Hackert, Audrey Y. J. Hensels, Casper D. J. den Heijer, Christian J. P. A. Hoebe, Paul H. M. Savelkoul, Lieke B. van Alphen · 2022 · Frontiers in Microbiology
58. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic
    Andreas C. Chrysostomou, Bram Vrancken, George Koumbaris, George Themistokleous, Antonia Aristokleous, Christina Masia, Christina Eleftheriou, Costakis Iοannou, Dora C. Stylianou, Marios Ioannides et al. · 2021 · Viruses
59. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19
    Jesús Zepeda–Cervantes, Daniel Martínez-Flores, Josué O. Ramírez‐Jarquín, Ángeles C. Tecalco-Cruz, Noé Santiago Alavez-Pérez, Luis A. Vaca, Rosa Elena Sarmiento Silva · 2022 · Viruses
60. Summarize of the Available Molecular Methods for Detection of Sars-Cov-2 During the Ongoing Pandemic
    Fabio Arena, Simona Pollini, Gian María Rossolini, Maurizio Margaglione · 2021 · Preprints.org
61. Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York
    Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Samuel Levine, Fritz François, Eduardo Iturrate, Guiqing Wang, Meike Dittmann, Jennifer Lighter et al. · 2022 · EBioMedicine
62. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant
    Sergio Buenestado‐Serrano, Raúl Recio, Pedro J. Sola‐Campoy, Pilar Catalán, María Dolores Folgueira, Jennifer Villa, Irene Muñoz Gallego, Víctor Manuel de la Cueva, María Ángeles Meléndez, Cristina Andrés-Zayas et al. · 2021 · Enfermedades Infecciosas y Microbiología Clínica
63. Robust clinical detection of SARS‐CoV‐2 variants by RT‐PCR/MALDI‐TOF multitarget approach
    Matthew M. Hernandez, Radhika Banu, Ana Silvia Gonzalez-Reiche, Adriana van de Guchte, Zenab Khan, Paras Shrestha, Liyong Cao, Feng Chen, Huanzhi Shi, Ayman Hanna et al. · 2021 · Journal of Medical Virology
64. Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-2
    Alexandra A. Nikonova, Е. Б. Файзулоев, Anastasiia V. Gracheva, Igor Yu. Isakov, В. В. Зверев · 2021 · Acta Naturae
65. Spike Mutations in SARS-CoV-2 AY Sublineages of the Delta Variant of Concern: Implications for the Future of the Pandemic
    Daniele Focosi, Fabrizio Maggi, Scott A. McConnell, Arturo Casadevall · 2022 · Future Microbiology
66. Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern
    Christian Setz, Maximilian Große, Janina Auth, Maria Fröba, Pia Rauch, Alexander Bausch, Matthew B. Wright, Ulrich Schubert · 2022 · International Journal of Molecular Sciences
67. Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7
    Marek Widera, Barbara Mühlemann, Victor M. Corman, Tuna Toptan, Jörn Beheim-Schwarzbach, Niko Kohmer, Julia A. Schneider, Annemarie Berger, Talitha Veith, Christiane Pallas et al. · 2021 · Microorganisms
68. Genomic and Epidemiological Analysis of SARS-CoV-2 Viruses in Sri Lanka
    Chandima Jeewandara, Deshni Jayathilaka, D.M.S.H.K. Ranasinghe, Sharon Nienyun Hsu, Dinuka Ariyaratne, Tibutius T. P. Jayadas, Deshan Madusanka, Benjamin B. Lindsey, Laksiri Gomes, Matthew D. Parker et al. · 2021 · Frontiers in Microbiology
69. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia
    Wasfi Farès, Kaïs Ghedira, Mariem Gdoura, Anissa Chouikha, S Boubaker, Marwa Khedhiri, Kaouthar Ayouni, Asma Lamari, Henda Touzi, Walid Hammemi et al. · 2021 · Microbiology Spectrum
70. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era
    Ender Volkan · 2021 · Molecular Biotechnology
71. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse
    Sarvin Sanaie, Elham Golipour, Ali Shamekh, Mohammad Reza Sadaie, Ata Mahmoodpoor, Mehdi Yousefi · 2021 · International Immunopharmacology
72. Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike’s Dynamics
    Jorge González-Puelma, Jacqueline Aldridge, Marco Montes de, Mónica Pinto, Roberto Uribe-Paredes, José Fernández-Goycoolea, Diego Álvarez-Saravia, Hermy Álvarez, Gonzalo Encina, Thomas Weitzel et al. · 2021 · Viruses
73. Structural Analysis of Spike Protein Mutations in the SARS-CoV-2 P.3 Variant
    Bascos, Neil Andrew D., Mirano-Bascos, Denise, Saloma, Cynthia P. · 2021
74. Molecular epidemiology of SARS-CoV-2 in Cyprus
    Jan Richter, Pavlos Fanis, Christina Tryfonos, Dana Koptides, George Krashias, Stavros Bashiardes, Andreas Hadjisavvas, Maria A. Loizidou, Anastasis Oulas, Denise Alexandrou et al. · 2021 · PLoS ONE
75. A SARS-CoV-2: Companion Animal Transmission and Variants Classification
    Rachana Pandit, Qiana L. Matthews · 2023 · Pathogens
76. Recurrent independent emergence and transmission of SARS-CoV-2 Spike amino acid H69/V70 deletions
    Ravindra K. Gupta, Steven A. Kemp, William T. Harvey, Spyros Lytras, Alessandro M. Carabelli, David L. Robertson · 2021 · Research Square
77. Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein
    Stefano Borocci, Carmen Cerchia, Alessandro Grottesi, Nico Sanna, Ingrid G. Prandi, Nabil Abid, Andrea R. Beccari, Giovanni Chillemi, Carmine Talarico · 2021 · International Journal of Molecular Sciences
78. Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide
    Yeon-Ju Kim, Eun‐Jin Kim, Sangwon Lee, Donghyok Kwon · 2021 · Osong Public Health and Research Perspectives
79. OmniSARS2: A Highly Sensitive and Specific RT-qPCR-Based COVID-19 Diagnostic Method Designed to Withstand SARS-CoV-2 Lineage Evolution
    Eduarda Carvalho-Correia, Carla Calçada, Fernando Branca, Nuria Estévez‐Gómez, Loretta De Chiara, Nair Varela, Pilar Gallego‐García, David Posada, Hugo Manuel Lopes de Sousa, João Carlos Sousa et al. · 2021 · Biomedicines
80. A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients
    Solat Eslami, Mark Charles Glassy, Soudeh Ghafouri‐Fard · 2021 · Gene
81. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation
    J.A. Rodriguez, J. Gonzalez, C.E. Arboleda-Bustos, N. Mendoza, C. Martinez, Andrés Mauricio Pinzón · 2022 · Chemico-Biological Interactions
82. Computational investigation of the increased virulence and pathogenesis of SARS-CoV-2 lineage B.1.1.7
    N. Arul Murugan, Prashanth S. Javali, Chitra Jeyaraj Pandian, Muhammad Akhtar Ali, Vaibhav Srivastava, Jeyakanthan Jeyaraman · 2022 · Physical Chemistry Chemical Physics
83. Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy
    Michele Equestre, Cinzia Marcantonio, Nadia Marascio, Federica Centofanti, Antonio Martina, Matteo Simeoni, Elisabetta Suffredini, Giuseppina La Rosa, Giusy Bonanno Ferraro, Pamela Mancini et al. · 2023 · Microorganisms
84. A multiple-step in silico screening protocol to identify allosteric inhibitors of Spike–hACE2 binding
    Jingchen Zhai, Xibing He, Viet Hoang Man, Yuchen Sun, Beihong Ji, Lianjin Cai, Junmei Wang · 2022 · Physical Chemistry Chemical Physics
85. AutoVEM: An automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution
    Binbin Xi, Dawei Jiang, Shuhua Li, Jerome Rumdon Lon, Yunmeng Bai, Shudai Lin, Meiling Hu, Yuhuan Meng, Yimo Qu, Yuting Huang et al. · 2021 · Computational and Structural Biotechnology Journal
86. An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?
    Hanieh Beyrampour-Basmenj, Morteza Milani, Abbas Ebrahimi Kalan, Ziyad Ben Taleb, Kenneth Daniel Ward, Ghader Dargahi Abbasabad, Zeynab Aliyari Serej, Mohammad Ebrahimi Kalan · 2021 · Public health reviews
87. Jumping a Moving Train: SARS-CoV-2 Evolution in Real Time
    Ahmed M. Moustafa, Paul Joseph Planet · 2021 · Journal of the Pediatric Infectious Diseases Society
88. Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA
    Peter T. Skidmore, Emily A. Kaelin, LaRinda A. Holland, Rabia Maqsood, Lily I. Wu, Nicholas J. Mellor, Joy M. Blain, Valerie K. Harris, Joshua LaBaer, Vel Murugan et al. · 2021 · Emerging infectious diseases
89. Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS‐CoV‐2 variants
    Rafael E. Guerrero-Preston, Vanessa Rivera‐Amill, Karem Caraballo, Sebastián Rodríguez‐Torres, Ana Purcell‐Wiltz, Andrea A. García, Raphael Sánchez Torres, Fernando Tadeu Zamunér, Claudio Zanettini, Matthew J. MacKay et al. · 2022 · Immunity Inflammation and Disease
90. Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assay
    Viera Kováčová, Kristína Boršová, Evan David Paul, Monika Radvánszka, Roman Hajdu, Viktória Čabanová, Monika Slavíková, Martina Ličková, Ľubomíra Lukáčiková, Andrej Belák et al. · 2021 · medRxiv
91. Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 binding
    Marta Alenquer, Filipe Ferreira, Diana Lousa, Mariana Valério, Mónica Medina-Lopes, Marie‐Louise Bergman, Juliana Gonçalves, Jocelyne Demengeot, Ricardo B. Leite, Jingtao Lilue et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
92. Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its first variants in fourplex real-time quantitative reverse transcription-PCR assays
    Mathieu Durand, Philippe Thibault, Simon Lévesque, Ariane Brault, Alex Carignan, Louis Valiquette, Philippe Martin, Simon Labbé · 2021 · Microbial Cell
93. The Infectivity and Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
    Youchun Wang, Jiajing Wu, Li Zhang, Yue Zhang, Haixin Wang, Ruxia Ding, Jianhui Nie, Qianqian Li, Shuo Liu, Yongxin Yu et al. · 2021 · Research Square
94. SARS-CoV-2 variants from COVID-19 positive cases in the Free State province, South Africa from July 2020 to December 2021
    Peter N. Mwangi, Javan Okendo, Milton T. Mogotsi, Ayodeji Emmanuel Ogunbayo, Olusesan Adeyemi Adelabu, Hlengiwe Sondlane, Makgotso Golda Maotoana, Lutfiyya Mahomed, Molefi Daniel Morobadi, Sabeehah Vawda et al. · 2022 · Frontiers in Virology
95. Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs
    Camila Ferreira Thé Pontes, Victoria Ruiz‐Serra, Rosalba Lepore, Alfonso Valencia · 2021 · Computational and Structural Biotechnology Journal
96. COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials
    Antonios M. Diab, Bruce Carleton, Kerry B. Goralski · 2021 · Canadian Journal of Physiology and Pharmacology
97. Genome Similarities between Human-Derived and Mink-Derived SARS-CoV-2 Make Mink a Potential Reservoir of the Virus
    Mohammad Khalid, Anas Alshishani, Yousef Al‐Ebini · 2022 · Vaccines
98. Genomic epidemiology and emergence of SARS-CoV-2 variants of concern in the United Arab Emirates
    Habiba S. AlSafar, Mohammed Saleh Albreiki, Mira Mousa, Syafiq Kamarul Azman, Hema Vurivi, Fathimathuz Zehra Waasia, Dymitr Ruta, Farida Ismail Al Hosani, Shereena Al Mazrouei, Rowan M. Abuyadek et al. · 2022 · Scientific Reports
99. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant
    Sergio Buenestado‐Serrano, Raúl Recio, Pedro J. Sola‐Campoy, Pilar Catalán, María Dolores Folgueira, Jennifer Villa, Irene Muñoz Gallego, Víctor Manuel de la Cueva, María Ángeles Meléndez, Cristina Andrés-Zayas et al. · 2022 · Enfermedades infecciosas y microbiologia clinica (English ed )
100. Evolution of the SARS-CoV-2 pandemic in India
     Varsha Atul Potdar, Sarah Cherian · 2022 · Medical Journal Armed Forces India